Clinical Trial Update: Gene Therapy for Beta-Thalassemia Major Using Autologous Hematopoietic Stem Cell Genetically Modified [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for autologous gene therapy for beta-thalassemia major in Phase 1/2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Beta Thalassemia Major
• Beta-thalassemia

Snippet

Sponsor: Nanfang Hospital, Southern Medical University | Conditions: Beta Thalassemia Major | Phase 1, Phase 2 | Status: UNKNOWN